| Literature DB >> 23581665 |
Abstract
Much international debate over access to medicines focuses on whether patent law accords with international human rights law. This article argues that this is the wrong question to ask. Following an analysis of both patent and human rights law, this article suggests that the better approach is to focus on national debates over the best calibration of patent law to achieve national objectives.Entities:
Mesh:
Year: 2013 PMID: 23581665 DOI: 10.1111/jlme.12013
Source DB: PubMed Journal: J Law Med Ethics ISSN: 1073-1105 Impact factor: 1.718